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CD1d presents lipid antigens to natural killer T cells. In this issue of Immunity, Wun et al. (2011) andMallevaey
et al. (2011) explore the molecular details of nonself lipid discrimination and self-recognition.Invariant natural killer T (iNKT) cells are
a unique lineage of ab T cells that recog-
nize lipid-based antigens in the context
of the major histocompatibility complex
(MHC) class I-like molecule, CD1d. Upon
stimulation, iNKT cells respond rapidly
and potently, producing cytokines that
have broad immunomodulatory effects.
The strongest stimulus for iNKT cells
is the agonist a-galactosylceramide
(a-GalCer), making it an important target
for immune therapeutics. Subtle changes
in a-GalCer structure have been shown to
have a profound quantitative and qualita-
tive impact on iNKT cell activation,
including biased production of T helper 1
(Th1) cell or Th2 cell cytokines. However,
the importance of T cell receptor (TCR)
recognition of these variants in contrib-
uting to this bias has been unclear.
Another intriguing aspect of iNKT cells is
their intrinsic autoreactivity. Under the
right conditions, iNKT cells can become
activated in a CD1d-dependent fashion
in the absence of exogenous antigen.
What these ‘‘right’’ conditions are in the
context of CD1d has been the subject of
much study and debate. Do iNKT cells
have an intrinsic affinity for CD1d or are
they recognizing a particular self-lipid-
CD1d complex? Two papers in this issue
of Immunity shed light on these key ques-
tions of ‘‘nonself’’ and ‘‘self’’ recognition
by mouse iNKT cells. Wun et al. (2011)
provide a comprehensive analysis of the
relationship between structure, kinetics,
and functional outcomes of iNKT cell
recognition of CD1d-presenting a-GalCer
and a panel of a-GalCer variants called
‘‘altered glycolipid ligands’’ (AGLs).
Meanwhile, Mallevaey et al. (2011)
employ clever engineering of iNKT-TCRs
to define the molecular underpinning of
‘‘self’’-CD1d recognition and reactivity.
The name ‘‘invariant’’ NKT cell comes
from the restricted use of specific V region
domains in their ab TCRs. In the mouse,iNKT-TCRs are composed of an invariant
Va14-Ja18 chain and semi-invariant Vb
domain. Vb8 is the b chain most preferen-
tially used; however, Vb7 and Vb2 are also
found in the mouse iNKT cell population.
Human iNKT-TCRs are more restricted,
using only Va24-Ja18 and Vb11 pairings.
The molecular basis for this iNKT-TCR
restriction comes from pivotal three-
dimensional structures of iNKT-TCRs in
complex with CD1d-presenting a-GalCer
(Borg et al., 2007; Pellicci et al., 2009).
These structures reveal a footprint unlike
that of conventional ab TCRs on pep-
tide-presenting MHCs (Figure 1) and
demonstrate the importance of the
conserved a chain in binding, in particular
the dominant role of residues encoded
by the Ja18 segment in the CDR3a loop
and the restriction of the Vb domain usage
resulting from important contacts made
by the CDR2b loop.
So what are the parameters that allow
for iNKT cell discrimination of antigen in
the context of CD1d? This is the key ques-
tion upon which these two papers focus.
Variants of a-GalCer, both in the lipid tails
and in the headgroup, have been shown
to modulate iNKT cell activity (Bai et al.,
2009; Oki et al., 2004; Yu et al., 2005).
To dissect the molecular basis of this
altered iNKT cell reactivity, Wun et al.
(2011) carefully selected variants of
a-GalCer and evaluated their recognition
through a comprehensive array of kinetic,
structural, and functional approaches.
They found that modifications to the
galactosyl head group (particularly those
at the 40 position) altered the affinity of
iNKT-TCR binding, consistent with their
previous findings (Borg et al., 2007; Wun
et al., 2008). Modifications to the lipid
tails did not generally affect iNKT-TCR
binding, as is the case with human iNKT-
TCRs (McCarthy et al., 2007). The excep-
tion to this trend was OCH, an a-GalCer
mimic differing only via a severely trun-Immunity 3cated sphingosine chain. OCH has been
shown previously to have a Th2 cell
biasing affect on iNKT cells (Oki et al.,
2004), which suggests a conformational
change of the F0 pocket inducing changes
in TCR affinity (McCarthy et al., 2007).
However, it has remained unclear whether
the iNKT-TCR recognizes the CD1d-OCH
complex differently than CD1d-a-GalCer.
Wun et al. (2011)’s structure of iNKT-TCR-
CD1d-OCH revealed an identical footprint
to that of a-GalCer, so, combined with the
unliganded structure of CD1d-OCH
showing subtle structural differences
(Sullivan et al., 2010), the authors postu-
late that binding of the iNKT-TCR thus
requires enforcement of an ‘‘induced fit’’
that could alter the kinetics of signaling
and contribute to the previously observed
differences in functional outcome.
When the authors, with primary iNKT
cells, compared CD1d-AGL-induced
proliferation, cytokine secretion, and the
kinetic measurements of iNKT-TCRs-
CD1d-AGL binding, they were unable to
discern a clear correlation between these
three parameters. The general discor-
dance between these measurements
supported previous reports that other
factors, such as differences in antigen
processing and presentation (Bai et al.,
2009; Im et al., 2009; Oki et al., 2004),
play a key role in iNKT cell-CD1d-
antigen-dependent stimulation.
One of the most enlightening aspects
of this work was the crystal structures of
complexes between the iNKT-TCR and
CD1d presenting five of the investigated
AGLs. In these structures, the iNKT cell
footprint on each CD1d-AGL was essen-
tially identical, with almost all contacts
between the iNKT-TCR and CD1d con-
served. Most profound was the lack of
substantial structural differences between
these structures, which provides a clear
hypothesis for why some mouse iNKT
cells respond differently to modifications4, March 25, 2011 ª2011 Elsevier Inc. 281
Figure 1. The Invariant Footprint of the iNKT-TCR on CD1d
The docking mode or ‘‘footprint’’ of iNKT-TCRs on CD1d (left) differs substantially from that of
conventional ab TCR recognition of peptide-MHC complexes (right). Superposition of the various
iNKT-TCR:CD1d-antigen complexes reveals that TCR CDR loop contacts (shown as footprints) with the
a helices of CD1d (shown in white) vary little from complex to complex, despite structurally diverse
antigens presented by CD1d (a-GalCer is shown as an example in yellow). In contrast, the CDR loops
of conventional ab TCRs can establish a range of contacts with their highly polymorphic MHC ligands,
shown as footprints on the surface of an MHC (white)-peptide (yellow) complex.
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at the 40 position. Indeed, the authors
found that iNKT cells with Vb7 in their
TCRs when stimulated with a-GalCer
analogs that lack a 40-OH appear to have
superior proliferation capacity over those
that use the preferred Vb8.2. This sug-
gests that the multiple Vb domain usage
in mouse iNKT cells endows these cells
with an increased flexibility for recognition
of CD1d-presented lipid antigens.
Whether human iNKT cells, which do not
vary in their Vb domain usage, have similar
flexibility (perhaps via their CDR3b loop)
remains a key question.
The conserved footprint of the iNKT-
TCR on CD1d revealed in Wun et al.
(2011)’s structures provides an ideal
segue into the second paper byMallevaey
et al. (2011). Here, the authors sought to
investigate iNKT cells’ ability to recognize
CD1d without exogenous antigen. The
immeasurably low affinity of these inter-
actions has stymied any detailed molec-
ular studies thus far, so to circumvent
this problem, Mallevaey et al. (2011) engi-
neered a set of ‘‘sticky’’ iNKT-TCRs,
randomized at the CDR3b and selected
to bind ‘‘empty’’ CD1d. They provide a
detailed analysis of how these engineered
iNKT-TCRs bound to CD1d and showed
that this recognition was not necessarily
antigen specific. The key finding of this
paper is that despite the engineered high
affinity, the footprint of these artificial
iNKT-TCRs on CD1d presenting ‘‘self’’282 Immunity 34, March 25, 2011 ª2011 Else(here phosphatidylinositol) is essentially
identical to that of naturally derived
iNKT-TCRs. This suggests that the
CDR3b can be an important factor in
iNKT-TCR interactions, but that it does
not change substantially where the other
loops bind to CD1d, nor is there a require-
ment for this loop to contact antigen. The
authors were able to further dissect the
enhanced binding down to key hydro-
phobic residues found at the N terminus
of the high-affinity CDR3b loops. Re-
vealed in their crystal structure, these
hydrophobic residues interact with corre-
sponding nonpolar residues on CD1d to
form a ‘‘hydrophobic cap,’’ and it is these
interactions that fundamentally change
the affinity of the iNKT-TCR to CD1d.
This finding suggests that iNKT-TCRs
endowed naturally with these affinity-
enhancing mutations may simply be
deleted during thymic selection.
Another important question is whether
these enhanced iNKT-TCRs recognize
all endogenous antigens in the same
way. Although these iNKT-TCRs still
bound CD1d-a-GalCer and also stained
equally well CD1d transfectants from a
range of cell types (insect, mouse, and
human), clear differences were evident
when specific antigens were tested via
tetramer staining. Lipids containing small
polar headgroups showed strong tet-
ramer staining of an affinity-enhanced
iNKT hybridoma whereas those with
large, bulky headgroups tended to havevier Inc.reduced staining, suggesting that for
autoreactivity, antigen is important only
when it gets in theway. Even though these
engineered iNKT-TCRs may have artifi-
cially enforced a specific recognition
mode that is only a sampling of those
present in the native population, the find-
ings demonstrate the importance of the
CDR3b loop in antigen recognition and
promote the idea that despite being
invariant at five CDR loops, diversity at
the sixth matters.
Together, these two papers expand our
understanding of the potential diversity of
responses at the cellular and iNKT cell
population level and directly relate this
diversity to the molecular architecture of
the iNKT-TCR-CD1d interaction. Because
these studies center on mouse iNKT cells,
it is intriguing to ask whether these con-
clusions can be extended to the homolo-
gous human system. Does the strict
restriction of Vb11 usage in human iNKT
cells change the game, placing more
influence on variation in the CDR3b loop,
or do other adaptations to antigen recog-
nition strategy by iNKT cells exist of which
we are presently unaware? Furthermore,
there are no structural data on how
‘‘natural’’ iNKT-TCRs recognize nongly-
colipid antigens; will this strict footprint
be conserved with structurally divergent
lipid-ligands?REFERENCES
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Activation of the RIG-I signalingmolecule is essential for antiviral immunity butmechanisms downmodulating
the response are ill defined. In this issue of Immunity, Rajput et al. (2011) describe caspase-8-mediated RIP1
cleavage as a key step for restricting RIG-I signaling.The innate immune system senses micro-
bial pathogens through pattern recogni-
tion receptors (PRRs) that recognize path-
ogen-associated molecular patterns
(Takeuchi and Akira, 2010). PRR ligation
triggers conserved intracellular signaling
pathways that drive proinflammatory re-
sponses, which are crucial for productive
innate and adaptive immunity and re-
quired for host protection. Still, inflamma-
tory responses cannot last permanently
and innate immune signaling needs to
be negatively regulated and terminated
to avoid tissue damage and autoimmune
disease. Although the last decade has
seen a rapid progress in deciphering the
pathways that activate innate immunity,
the mechanisms that limit these re-
sponses to secure homeostasis are not
well defined.
The recognition of viruses by the innate
immune system depends mainly on the
ability to discriminate viral nucleic acids
from host RNA or DNA. The major PRRs
for virus-derived RNA, originating from
either genomic RNA or replication inter-
mediates, are the retinoic acid inducible
gene I (RIG-I)-like helicases (RLHs)
including RIG-I, MDA5, and LGP2 (Yo-
neyama and Fujita, 2009). RIG-I itself is
required for the detection of specific
RNA viruses including Newcastle disease
virus, Sendai virus (SeV), vesicular stoma-titis virus, influenza virus, and Japanese
encephalitis virus. This receptor
possesses a central DExD/H-box RNA
helicase domain and a C-terminal
repressor domain for ligand binding
together with two caspase recruitment
domains (CARDs) for signal propagation.
RNA sensing by RIG-I induces an intra-
molecular conformational change that
exposes the CARDs to allow association
of RIG-I with the mitochondrial antiviral
signaling adaptor (MAVS) (Yoneyama
and Fujita, 2009). These events enable
the formation of a large mitochondria-
associated complex that contains several
conserved signaling proteins, which also
participate in other innate and inflamma-
tory pathways. These factors include the
serine-threonine kinase receptor interact-
ing protein 1 (RIP1) together with TRADD,
FADD, and caspase-8, all of which
have additional well-recognized roles in
TNF-receptor (TNFR) signaling pathways
(Yoneyama and Fujita, 2009). Further
recruitment of the regulatory IKK subunit
NEMO to the activated RIG-I complex is
essential for downstream signaling to
interferon regulatory factors (IRFs) and
NF-kB via IKK-related kinases.
In the present work, Rajput et al. (2011)
describe a mechanism for how RIG-I
signaling is limited in both duration and
magnitude. This intriguing study wasprompted by the surprising and incidental
finding that a lentivirus, which specifically
expresses a caspase-8 siRNA, potently
inhibited the proliferation of fibroblast
cell lines. These growth-inhibitory effects
were directly caused by hyperactive
IRF3 and were associated with an
increased expression of interferon-stimu-
lated genes. In contrast to lentiviral in-
fection, transfection of oligonucleotide
caspase-8 siRNA affected neither IRF3
activity nor cell proliferation. The authors
therefore hypothesized that the infection
with the lentivirus would trigger an IRF3
response, which is substantially en-
hanced in the absence of caspase-8.
Consistently, SeV infection or transfection
of specific RIG-I ligands resulted in a
massively enhanced IRF3 signal in fibro-
blasts or primary keratinocytes from
caspase-8-deficient mice. Moreover,
SeV-induced IRF3 signaling was strongly
augmented in conditional caspase-8-
deficient hepatocytes in vivo.
To understand the molecular basis for
these observations, Rajput et al. (2011)
studied functional interactions of cas-
pase-8 and RIG-I. They revealed that
caspase-8 can directly bind to RIG-I and
in addition observed a virus-induced
cotranslocation of caspase-8 and RIP1
to the mitochondrial RIG-I complex. Im-
portantly, RIP1 was gradually cleaved4, March 25, 2011 ª2011 Elsevier Inc. 283
